Structure of AKR1C3 with 3-phenoxybenzoic acid bound
Jackson, V.J., Yosaatmadja, Y., Flanagan, J.U., Squire, C.J.(2012) Acta Crystallogr Sect F Struct Biol Cryst Commun 68: 409-413
- PubMed: 22505408 
- DOI: https://doi.org/10.1107/S1744309112009049
- Primary Citation of Related Structures:  
3UWE - PubMed Abstract: 
Aldo-keto reductase 1C3 (AKR1C3) is a human enzyme that catalyzes the NADPH-dependent reduction of steroids and prostaglandins. AKR1C3 overexpression is associated with the proliferation of hormone-dependent cancers, most notably breast and prostate cancers. Nonsteroidal anti-inflammatory drugs (NSAIDs) and their analogues are well characterized inhibitors of AKR1C3. Here, the X-ray crystal structure of 3-phenoxybenzoic acid in complex with AKR1C3 is presented. This structure provides useful information for the future development of new anticancer agents by structure-guided drug design.
Organizational Affiliation: 
School of Biological Sciences, University of Auckland, Private Bag 92019, Victoria St. West, Auckland, New Zealand.